Project Title: A phase 2 Open - Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Torelability of combinations of bedaquiline, moxifloxacin, PA-824 and pyrazinamide during 8 weeks of treatment in Adult Subjects with Newly Diagnosed Drug - Sensitive or Multi Drug - Resistant, Smear- Positive Pulmonary Tuberculosis

Project Description: xxx xxx Read more

Principal Investigator : Fredrick Haraka

Department Name : BRCT

Time frame: (2014-09-01) - (2018-01-31)

Funding Partners
Global Alliance for TB Drug Development (TB-Alliance) (Normal)
External Collaborating Partners
None added yet.